All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Which gene mutations play a role in predicting survival following JAKi failure?

During the EHA2021 Virtual Congress, the MPN Hub spoke with James England, Princess Margaret Cancer Center, Toronto, CA. We asked, Which gene mutations play a role in predicting survival following JAK inhibitor (JAKi) failure?

Which gene mutations play a role in predicting survival following JAKi failure?

In this video, England talks about the clinical and molecular features of JAKi failure in patients with myelofibrosis. He discusses the findings of a retrospective cohort study analyzing a dataset of 113 patients with myelofibrosis.

 

Share:
More about...